Kalindi Parmar

Company: Dana-Farber Cancer Institute

Job title: Associate Director, Center for DNA Damage and Repair

Seminars:

Fireside Chat: How Can We Holistically Prioritise Combination Strategies Across the DDR Landscape & Leverage These to Tackle PARP inhibitor resistance? 11:30 am

How can we effectively integrate combination strategies that target complementary DNA damage response (DDR) pathways, such as combining PARP inhibitors with emerging DDR modulators like USP1 inhibitors, to enhance therapeutic efficacy? What role do biomarkers, particularly those related to homologous recombination repair (HRR) deficiencies, play in guiding the selection of optimal combination therapies tailored to…Read more

day: Day One